The angiotensin AT 2 receptor modulates renal production of cyclic guanosine 3 Ј , 5 Ј -monophosphate (cGMP; J. Clin. Invest. 1996Invest. . 97:1978Invest. -1982. In the present study, we hypothesized that angiotensin II (Ang II) acts at the AT 2 receptor to stimulate renal production of nitric oxide leading to the previously observed increase in cGMP. Using a microdialysis technique, we monitored changes in renal interstitial fluid (RIF) cGMP in response to intravenous infusion of the AT 2 receptor antagonist PD 123319 (PD), the AT 1 receptor antagonist Losartan, the nitric oxide synthase (NOS) inhibitor nitro-L -arginine-methyl-ester ( L -NAME), the specific neural NOS inhibitor 7-nitroindazole (7-NI), or Ang II individually or combined in conscious rats during low or normal sodium balance.Sodium depletion significantly increased RIF cGMP. During sodium depletion, both PD and L -NAME caused a similar decrease in RIF cGMP. Combined administration of PD and L -NAME decreased RIF cGMP to levels observed with PD or L -NAME alone or during normal sodium intake.During normal sodium intake, Ang II caused a twofold increase in RIF cGMP. Neither PD nor L -NAME, individually or combined, changed RIF cGMP. Combined administration of Ang II and either PD or L -NAME produced a significant decrease in RIF cGMP compared with that induced by Ang II alone. Combined administration of Ang II, PD, and L -NAME blocked the increase in RIF cGMP produced by Ang II alone.During sodium depletion, 7-NI decreased RIF cGMP, but the reduction of cGMP in response to PD alone or PD combined with 7-NI was greater than with 7-NI alone. During normal sodium intake, 7-NI blocked the Ang II-induced increase in RIF cGMP. PD alone or combined with 7-NI produced a greater inhibition of cGMP than did 7-NI alone. During sodium depletion, 7-NI (partially) and L -NAME (completely) inhibited RIF cGMP responses to L -arginine.These data demonstrate that activation of the reninangiotensin system during sodium depletion increases renal nitric oxide production through stimulation by Ang II at the angiotensin AT 2 receptor. This response is partially mediated by neural NOS, but other NOS isoforms also contribute to nitric oxide production by this pathway. (